According to Allogene Therapeutics 's latest financial reports the company's current earnings (TTM) are -HK$2.12 B. In 2023 the company made an earning of -HK$2.46 B an increase over its 2022 earnings that were of -HK$2.62 B.The earnings displayed on this page is the company's Pretax Income.